NFKB1 and Miyoshi myopathy: HMGB1 is a key mediator of chronic inflammation in MM, leading to Nalp3 inflammasome activation, macrophages accumulation, interleukin (IL)-1β and TNF-α secretion, and thus to activation of the NF-κB pathway, which increases cell survival and tumor growth after asbestos exposure [50].